Teriparatide for Joint Erosions in Rheumatoid Arthritis: The TERA Trial (TERA)

Clinical Trial ID NCT01400516

PubWeight™ 0.00^‹?›

🔗 Visit the ClinicalTrials.gov page for NCT01400516

Top papers

Rank	Title	Journal	Year	PubWeight™‹?›
1	Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study Group.	N Engl J Med	1998	4.38
2	Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis.	N Engl J Med	1997	4.18
3	Fractures after rheumatoid arthritis. A population-based study.	Arthritis Rheum	1984	2.85
4	Bone mineral density and frequency of osteoporosis in female patients with rheumatoid arthritis: results from 394 patients in the Oslo County Rheumatoid Arthritis register.	Arthritis Rheum	2000	2.71
5	Rheumatoid arthritis, corticosteroid therapy and hip fracture.	Ann Rheum Dis	1995	2.10
6	Prevalence of rheumatoid arthritis in persons 60 years of age and older in the United States: effect of different methods of case classification.	Arthritis Rheum	2003	1.93
7	Risk of vertebral fracture in women with rheumatoid arthritis.	BMJ	1993	1.87
8	Parathyroid hormone treatment can reverse corticosteroid-induced osteoporosis. Results of a randomized controlled clinical trial.	J Clin Invest	1998	1.75
9	Risedronate therapy prevents corticosteroid-induced bone loss: a twelve-month, multicenter, randomized, double-blind, placebo-controlled, parallel-group study.	Arthritis Rheum	1999	1.58
10	Increased bone mass with pamidronate treatment in rheumatoid arthritis. Results of a three-year randomized, double-blind trial.	Arthritis Rheum	1996	1.19
11	The effect of rheumatoid arthritis and steroid therapy on bone density in postmenopausal women.	Arthritis Rheum	1993	1.19
12	Fractures in rheumatoid arthritis: an evaluation of associated risk factors.	J Rheumatol	1993	1.18